HCA Holdings (NYSE: HCA) reported Q1 EPS of $6.45, $0.67 better than the analyst estimate of $5.78. Revenue for the quarter came in at $18.32 billion versus the consensus estimate of $18.26 billion.

GUIDANCE

2025 Guidance

Today, the Company reaffirmed its 2025 estimated guidance ranges issued on January 24, 2025.

The Company’s guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding volume growth coupled with an anticipated mostly stable operating environment, payer mix, the ongoing impacts of the two major 2024 hurricanes, the impact of current and future health care public policy developments, as well as general business or economic conditions, including inflation, and the impact of trade policies, including tariffs, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.

Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.